首页> 外文期刊>Securities Regulation Law Journal >Will Delaware's Decision in Allegran Botox the Wrinkles in Securities Litigation?
【24h】

Will Delaware's Decision in Allegran Botox the Wrinkles in Securities Litigation?

机译:特拉华州在Allegran肉毒杆菌中的决定会否导致证券诉讼起皱纹?

获取原文
获取原文并翻译 | 示例
           

摘要

The life of the law has not been logic and it's hard to find a better example of Holmes's famous dictum than the rules governing American corporations. There are plenty of incongruities in this jurisprudence and the Delaware Supreme Court has just tried to rectify one in a case involving Allergan, Inc. entitled Pyott v. Louisiana Municipal Police Employees Retirement System. There a vice-chancellor in a lower Delaware court had allowed a derivative suit against the management of that company to go forward even though an identical action had been dismissdismissed by a California federal court. The Vice-Chancellor would have let the matter proceed in Delaware because he found the corporation's representation in the California case was inadequate.
机译:法律的生命力不是逻辑,因此,比起管理美国公司的规则,很难找到一个更好的霍姆斯著名法则的例子。该判例中存在很多不一致之处,特拉华州最高法院刚刚试图纠正涉及Allergan,Inc.的一个名为Pyott诉路易斯安那市政警察雇员退休制度的案子。特拉华州下级法院的一名副校长允许针对该公司管理层的衍生诉讼继续进行,即使加利福尼亚州联邦法院已驳回了同样的诉讼。副校长本来可以在特拉华州进行此事的,因为他发现该公司在加利福尼亚案件中的代理权不足。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号